Case Studies of Cardiac Resynchronization Therapy "Nonresponders"
1Section of Cardiac Electrophysiology, Department of Cardiovascular Medicine, Heart, and Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue/J2-2, Cleveland, OH 44195, USA.
Cardiac Electrophysiology Clinics
|June 17, 2022
Summary
Cardiac resynchronization therapy (CRT) outcomes differ significantly. This review presents cases of suboptimal CRT response, highlighting the complexity of patient care and the need for specialized optimization clinics.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) outcomes present a wide spectrum, from normalization of left ventricular function to adverse effects from biventricular pacing.
- Postoperative management of CRT patients is intricate, necessitating multidisciplinary input from electrophysiology, heart failure specialists, and cardiac imaging experts.
Purpose of the Study:
- To present cases of apparent suboptimal response to CRT.
- To highlight the challenges in managing CRT patients and the role of specialized optimization clinics.
Main Methods:
- Review of clinical cases from a dedicated CRT optimization clinic.
- Analysis of patient responses to biventricular pacing and subsequent management strategies.
Main Results:
- Identified instances of suboptimal CRT response requiring further intervention.
- Demonstrated the variability in patient outcomes despite CRT.
Conclusions:
- Patient response to CRT is highly variable, underscoring the need for individualized care.
- Dedicated CRT optimization clinics are crucial for managing complex cases and improving patient outcomes.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
01:22Heart Failure VI: Adjunct Therapies
26
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
26
01:29Cardiomyopathy V: Interprofessional Care
30
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
01:23Cardiopulmonary Resuscitation III: AED Use
66
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
66
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
74
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
74
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25